Placeholder Banner

2012 BIO Technology Transfer Symposium

October 3, 2012
BIO's Technology Transfer Symposium is right around the corner, next Monday, October 8th in fact. And whether you are planning on attending the BIO Investor Forum, the Tech Transfer offers a unique insight in to the value of biotech public-private partnerships.

The Tech Transfer highlights recent and successful early stage technology transfer deals from a variety of perspectives, including universities, government and venture capitalists. Attendees will learn about how technology transfer offices and industry are working together to commercialize early stage discoveries.

Program highlights include:

12:45 p.m. – 1:00 p.m.

BIO’s Technology Transfer Committee Chair: Mark Crowell, Executive Director and Associate Vice President for Innovation Partnerships and Commercialization, University of Virginia

1:00 p.m. – 1:30 p.m.

Keynote: Tom Thornton, General Manager, Strategic Alliances, Cleveland Clinic

1:30 pm - 2:45 pm

Collaborations between big pharma and academic research institutions are nothing new, but a recent wave of academic-industry collaborations seem to show that these tie-ups are becoming increasingly important to big pharma's business model.  Panelists will discuss what has changed about the way big pharma views these collaborations, and how do these deals differ from their predecessors.

Moderator: Janet E. Embretson, Attorney, Schwegman Lundberg Woessner

Panelists: Kevin P. Hurley, Director of Strategic Alliances and Assoc. Director of Therapeutic Development, Duke Translational Research Institute and John Hidalgo, Assoc. Director of Continuous Improvement Metrics, Global Development & Medical Affairs, Bristol-Myers Squibb

3:00 pm - 4:15 pm 

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, what can universities and start-ups expect in their right first-round financing structure? This panel will examine various funding sources, the factors that go into investment decisions and typical deal structures, as experienced investors explain the ins and outs of early stage financing deals.

Moderator: William Tucker, Executive Director, Innovation Alliances and Services, University of California Office of the President

Panelists: Ron Lennox, Partner, CHL Medical Partners and Dr. Heather M. Snyder, Senior Associate Director, Medical and Scientific Relations, Alzheimer's Association

  • Closing Remarks and Networking Reception

4:15 pm - 6:00 pm

To learn more about the BIO Technology Transfer Symposium, including registration and program information, please visit here. Registration is complimentary for credentialed members of the media and qualified investors.